1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VERONA PHARMA PLC - ADR
Verona Pharma Plc - ADR XNAS: VRNA
104.67 -0.16 (-0.15%)
15.6M

XNAS 14 Jul, 2025 5:30 PM (EDT)

Analyst Downgrade
Wells Fargo downgrades Verona Pharma to 'Equalweight'; cuts the target price to $107 See details

Verona Pharma Plc - ADR - VRNA - stock price prediction, stock price target, analyst ratings from 11 analysts

Verona Pharma Plc - ADR has a share price target of US$ 106, revenue growth forecast of 893.9%, and profit growth estimate of 107.5% for FY25, based on top 11 analyst calls.